Parkinnova Therapeutics
Driven by Expertise and Fueled by Passion
Parkinnova was founded in January 2024 by Dr. Lars van der Heide and Prof. dr. Marten Smidt. With decades of collective experience in molecular neuroscience, the founders recognized the urgent need for innovative and effective treatments for Parkinson’s disease, a chronic disorder that affects millions of people worldwide. Their passion for advancing the field and improving patients’ quality of life inspired the creation of Parkinnova Therapeutics. The company is currently housed at the Amsterdam Science Park, the heart of academic excellence in the Netherlands.
Meet our founders, Marten Smidt and Lars van der Heide.
Transforming Parkinson's treatment through targeted innovation
Our mission at Parkinnova is to improve the lives of those affected by Parkinson’s disease through innovative and targeted therapies. We are dedicated to advancing scientific understanding and pushing the boundaries of what’s possible through rigorous preclinical research. Using our expertise in molecular neuroscience, we strive to develop sustainable and effective treatment solutions, providing hope to patients and their families.
Our Mission
Our Vision
Envisioning a future free from the burdens of Parkinson's disease
Our vision is a world where Parkinson’s disease is no longer a devastating diagnosis. We see a future where individuals can live their lives to the fullest, free from the burden of motor symptoms and the limitations they bring. At Parkinnova Therapeutics, we are committed to working towards this goal through the development of an innovative and targeted approach and a dedication to scientific excellence.
Grounded in Scientific excellence, inspired by innovation
oUR vALUES
Scientific Excellence
We are committed to upholding the highest standards of scientific rigor and excellence in all our endeavors. We strive for precision, accuracy, and thoroughness in our research, development, and decision-making processes.
Innovation
We embrace a culture of innovation, constantly seeking new ideas, approaches, and technologies to advance Parkinson’s treatment. We encourage creativity, curiosity, and a willingness to challenge the status quo in pursuit of breakthrough solutions.
Patient-Centered
We prioritize the needs and well-being of patients and their families, placing them at the heart of everything we do. We are committed to developing therapies that enhance quality of life, empower individuals, and provide hope for a brighter future.
Collaboration
We believe in the power of collaboration and partnership. We actively seek opportunities to collaborate with patients, caregivers, healthcare professionals, and researchers to leverage collective expertise and resources for maximum impact.
We value your interest and look forward to connecting with you. For inquiries, more information, or to schedule a meeting, please click the button below.